GOODRX HOLDINGS INC-CLASS A (GDRX)

Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against GoodRx Holdings, Inc. (GDRX)

GoodRx Announces Date for 2024 Investor Day

GOODRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm

GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.

GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX

GDRX INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm

GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call

Why GoodRx Surged Today

The prescription-drug upstart got an upgrade from Wall Street.

Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says

Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025.

GoodRx Interim CEO Extends Commitment to Company

GoodRx stock climbs 6% following J.P. Morgan upgrade (NASDAQ:GDRX)

GoodRx (GDRX) shares got a boost Friday after J.P. Morgan upped its rating for the stock to overweight, citing accelerating topline growth. Read more here.

Why GoodRx Stock Soared Today

The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.

GoodRx (GDRX) Q4 2023 Earnings Call Transcript

GDRX earnings call for the period ending December 31, 2023.

GoodRx Reports Fourth Quarter and Full Year 2023 Results

GoodRx to Participate in Upcoming Investor Conferences

GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

GoodRx Announces Proposed Refinancing of First Lien Credit Facilities

The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

Goodrx stock rises on higher-than-expected Q4 preliminary results (NASDAQ:GDRX)

Goodrx (GDRX) shares gained as much as 9% premarket on Wednesday after the healthcare savings platform issued higher-than-expected sales for the fourth quarter

GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024

Election Edge: 7 Stocks to Snag Before the 2024 Presidential Race Heats Up

Election stocks include companies at the center of national conversation and those likely to get increased government funding.

Notable Two Hundred Day Moving Average Cross - GDRX